PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses.
Palaniyandi SS, Ferreira JC, Brum PC, Mochly-Rosen D. (2011) J. Cell. Mol. Med. 15(8):1769-77 [PubMed]